search
Back to results

Fetal Endoscopic Surgery for Spina Bifida (FESSB)

Primary Purpose

Neural Tube Defects, Spina Bifida, Open, Myelomeningocele

Status
Recruiting
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Fetoscopic repair of spina bifida
Sponsored by
Hospital Universitari Vall d'Hebron Research Institute
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Neural Tube Defects

Eligibility Criteria

18 Years - 50 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Maternal age > 18 years old
  • Singleton pregnancy
  • Gestational age between 18 0/7 weeks and 26 6/7 weeks
  • Isolated neural tube defect between T1 and S1
  • Cerebellar herniation (Chiari type II)

Exclusion Criteria:

  • Fetal anomalies non related to neural tube defect (NTD) including chromosomal abnormalities
  • Body mass index > 35 kg/m2
  • Maternal disorders contraindicating surgery
  • Genetic anomalies with poor prognosis
  • Sever kyphosis (>30º)

Sites / Locations

  • Hospital Universitari Vall d'HebronRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Fetoscopic repair of spina bifida

Arm Description

This is a single arm study, all patients will receive a fetoscopic repair of the spina bifida

Outcomes

Primary Outcome Measures

Capability to achieve successful closure of the neural tube defect by fetoscopic surgery (yes/no)
Binary variable (yes/no) describing if the neural tube defect has been successfully closed, (placode dissected and dropped into the open spinal canal, cystic tissue resected and edges closed to the midline), by fetoscopic surgery, and without conversion to open surgery

Secondary Outcome Measures

Operating time (minutes)
Time between the skin opening and skin closure
Fetoscopy time (minutes)
Time between the introduction of the first cannula and the removal of the last cannula
Hospital stay (days)
Time between hospital admission and discharge

Full Information

First Posted
October 3, 2017
Last Updated
October 16, 2017
Sponsor
Hospital Universitari Vall d'Hebron Research Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT03315637
Brief Title
Fetal Endoscopic Surgery for Spina Bifida
Acronym
FESSB
Official Title
Fetal Endoscopic Surgery for Spina Bifida
Study Type
Interventional

2. Study Status

Record Verification Date
October 2017
Overall Recruitment Status
Recruiting
Study Start Date
January 2015 (Actual)
Primary Completion Date
December 31, 2021 (Anticipated)
Study Completion Date
December 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospital Universitari Vall d'Hebron Research Institute

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
This study aims to assess the feasibility to perform a fetoscopic prenatal repair of an open neural tube defect, and secondly to assess the maternal, fetal and neonatal outcomes.
Detailed Description
Introduction: Spina bifida is a congenital malformation characterized by a failure in neural tube closure. Unprotected fetal neural tissue at the spine level undergoes not only progressive neurodegeneration in spinal cord, but also the impairment in brain development, hindbrain herniation or Chiari II malformation probably due to pressure disturbances resulting from a continuous leakage of cerebrospinal fluid through the defect. The neurological consequences at birth are irreversible and sometimes devastating, including paraplegia, sphincter urinary and fecal incontinence, hydrocephalus, cranial nerve disturbances, respiratory problems and death due to spinal cord injury and brain maldevelopment. Intrauterine fetal open repair of the defect has proved to improve hindbrain herniation and decrease the need of cerebrospinal shunting. Hypothesis: The investigators hypothesize that minimally invasive surgery of spina bifida is feasible and may minimize surgical aggression and obstetrical complications, with similar neonatal and neurological results. Intervention: In this study the investigators propose a fetoscopic skin closure technique. After a maternal laparotomy the uterus is exteriorized, the amniotic cavity is accessed by fetoscopic approach. The placode is dissected from the surrounding tissue and dropped into the opened spinal canal, untethered. Part of the cystic tissue is resected. The edges are then closed to the midline. Follow up: After surgery patients are followed up at the Fetal Medicine Unit every one or two weeks. The mode of delivery is decided according to obstetric criteria. Neonates will be examined at birth, and followed up regularly at least until 30 months. Patients are lifetime followed up by our Multidisciplinary myelomeningocele (MMC) Committee that comprises professionals from the Spina Bifida Unit, Neonatologists, Pediatric Surgeons, Pediatric Urologist, Pediatric Orthopedic Surgeons, Radiologists, Rehabilitation, Pathologists, Pediatric Neurosurgeons, Obstetricians and Fetal Therapists.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Neural Tube Defects, Spina Bifida, Open, Myelomeningocele, Fetal Disease, Hydrocephalus, Chiari Malformation Type 2, Congenital Abnormality, Surgery; Maternal, Uterus or Pelvic Organs, Affecting Fetus

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Fetoscopic repair of spina bifida
Arm Type
Experimental
Arm Description
This is a single arm study, all patients will receive a fetoscopic repair of the spina bifida
Intervention Type
Procedure
Intervention Name(s)
Fetoscopic repair of spina bifida
Intervention Description
Fetoscopic intrauterine repair of open spina bifida
Primary Outcome Measure Information:
Title
Capability to achieve successful closure of the neural tube defect by fetoscopic surgery (yes/no)
Description
Binary variable (yes/no) describing if the neural tube defect has been successfully closed, (placode dissected and dropped into the open spinal canal, cystic tissue resected and edges closed to the midline), by fetoscopic surgery, and without conversion to open surgery
Time Frame
Time of procedure (day 0)
Secondary Outcome Measure Information:
Title
Operating time (minutes)
Description
Time between the skin opening and skin closure
Time Frame
Time of procedure (day 0)
Title
Fetoscopy time (minutes)
Description
Time between the introduction of the first cannula and the removal of the last cannula
Time Frame
Time of procedure (day 0)
Title
Hospital stay (days)
Description
Time between hospital admission and discharge
Time Frame
Between procedure and delivery, up to 21 weeks
Other Pre-specified Outcome Measures:
Title
Post-operative hemoglobin (g/dL)
Description
Hemoglobin level after the procedure
Time Frame
24 hours after procedure
Title
Blood transfusion (yes/no)
Description
Binary variable describing if a transfusion of blood derivates is carried out between the time of procedure and discharge
Time Frame
Between procedure and discharge, up to 21 weeks
Title
Gestational age at delivery (weeks and days as x/7)
Description
Gestational age at birth
Time Frame
At birth, up to 21 weeks after procedure
Title
Surgery to delivery interval (days)
Description
Interval between surgery and birth
Time Frame
At birth, up to 21 weeks after procedure
Title
Premature rupture of membranes (PROM) (yes/no)
Description
Binary variable describing amniotic fluid leakage before the onset of labor
Time Frame
Between the procedure and 37 weeks of pregnancy (18 weeks after procedure)
Title
Chorioamnionitis (yes/no)
Description
Binary variable describing the presence of a chorioamnionitis between the procedure and birth
Time Frame
Between the procedure and birth, up to 21 weeks after procedure
Title
Oligohydramnios without PROM (yes/no)
Description
Binary variable describing the presence of a oligohydramnios (deepest pool < 2 cm) without evidence of vaginal amniotic fluid leakage
Time Frame
Between the procedure and birth, up to 21 weeks after procedure
Title
Placental abruption (yes/no)
Description
Binary variable describing the presence of a placental abruption
Time Frame
Between the procedure and birth, up to 21 weeks after procedure
Title
Mode of delivery (vaginal / cesarean)
Description
Binary variable describing the mode of delivery, vaginal or cesarean section
Time Frame
At birth, up to 21 weeks after procedure
Title
Uterine dehiscence (yes/no)
Description
Binary variable describing the presence of a uterine dehiscence, regardless of whether it is symptomatic or it is diagnosed at the time of cesarean section
Time Frame
At birth, up to 21 weeks after procedure
Title
Acute Pulmonary edema (yes/no)
Description
Binary variable describing the presence of a maternal pulmonary edema, regardless of the severity, between the procedure and discharge.
Time Frame
Between the procedure and birth, up to 21 weeks after procedure
Title
Closure of the spinal defect (yes/no)
Description
Binary variable describing the watertight closure of the defect
Time Frame
Between birth and 1 month of life
Title
Maintenance of the neurological level (Better / same / worse)
Description
Categorical variable describing if the postnatally assessed neurological level is better / same or worse than the level assessed prenatally before the procedure. It will be assessed by physical examination
Time Frame
1 month of life
Title
Reversal of Chiari malformation(completely reversed / mild improvement / no improvement) by MRI
Description
Categorical variable comparing the postnatal and prenatal MRI assessment of the Chiari malformation
Time Frame
1 month of life
Title
Ventriculoperitoneal shunting (yes/no)
Description
Binary variable describing the need of a ventriculoperitoneal shunting
Time Frame
Between birth and 12 months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Maternal age > 18 years old Singleton pregnancy Gestational age between 18 0/7 weeks and 26 6/7 weeks Isolated neural tube defect between T1 and S1 Cerebellar herniation (Chiari type II) Exclusion Criteria: Fetal anomalies non related to neural tube defect (NTD) including chromosomal abnormalities Body mass index > 35 kg/m2 Maternal disorders contraindicating surgery Genetic anomalies with poor prognosis Sever kyphosis (>30º)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Elena Carreras, PhD
Email
ecarreras@vhebron.net
First Name & Middle Initial & Last Name or Official Title & Degree
Nerea Maiz, PhD
Email
nmaiz@vhebron.net
Facility Information:
Facility Name
Hospital Universitari Vall d'Hebron
City
Barcelona
ZIP/Postal Code
08035
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Elena Carreras, PhD
Email
ecarreras@vhebron.net
First Name & Middle Initial & Last Name & Degree
Nerea Maiz, PhD
Email
nmaiz@vhebron.net

12. IPD Sharing Statement

Citations:
PubMed Identifier
27997256
Citation
Maroto A, Illescas T, Melendez M, Arevalo S, Rodo C, Peiro JL, Belfort M, Cuxart A, Carreras E. Ultrasound functional evaluation of fetuses with myelomeningocele: study of the interpretation of results. J Matern Fetal Neonatal Med. 2017 Oct;30(19):2301-2305. doi: 10.1080/14767058.2016.1247262. Epub 2017 Jan 16.
Results Reference
background
PubMed Identifier
28277363
Citation
Belfort MA, Whitehead WE, Shamshirsaz AA, Bateni ZH, Olutoye OO, Olutoye OA, Mann DG, Espinoza J, Williams E, Lee TC, Keswani SG, Ayres N, Cassady CI, Mehollin-Ray AR, Sanz Cortes M, Carreras E, Peiro JL, Ruano R, Cass DL. Fetoscopic Open Neural Tube Defect Repair: Development and Refinement of a Two-Port, Carbon Dioxide Insufflation Technique. Obstet Gynecol. 2017 Apr;129(4):734-743. doi: 10.1097/AOG.0000000000001941.
Results Reference
background

Learn more about this trial

Fetal Endoscopic Surgery for Spina Bifida

We'll reach out to this number within 24 hrs